Camille Marie Schubert

Employment

• Adelaide University Research/Health Economist

Education

• University of South Australia Bachelor of Pharmacy
• University of Adelaide Bachelor of Economics

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Response to: Comment on ‘The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis’
  Clinical and Public Health Guidelines 2026 DOI: 10.1002/gin2.70089
  +Save
• Guidelines addressing Motor Neurone Disease (MND): a scoping review
  Neurodegenerative Disease Management 2026 DOI: 10.1080/17582024.2025.2573608
  +Save
• The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis
  Clinical and Public Health Guidelines 2026 DOI: 10.1002/gin2.70080
  +Save
• Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02136-4
  +Save
• Health Economic Evaluation on Point of Care Antenatal Ultrasound in Rural and Remote Communities Globally: A Scoping Review
  Australasian Journal of Ultrasound in Medicine 2026 DOI: 10.1002/ajum.70040
  +Save
• NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study
  BMJ Open 2026 DOI: 10.1136/bmjopen-2025-108406
  +Save
• Evaluating the Clinical Utility of Genomic Sequencing After Perinatal Death
  Camille Schubert, Matilda R. Jackson, Christopher Barnett +4 more
  Clinical Genetics 2026 DOI: 10.1111/cge.70028
  +Save
• The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review Protocol
  Clinical and Public Health Guidelines 2025 DOI: 10.1002/gin2.70039
  +Save
• A systematic review to assess the utility of genomic autopsy using exome or genome sequencing in cases of congenital anomalies and perinatal death
  Genetics in Medicine 2024 DOI: 10.1016/j.gim.2024.101159
  +Save
• Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)
  Age and Ageing 2022 DOI: 10.1093/ageing/afac092
  +Save
• Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome
  BMJ Open 2020 DOI: 10.1136/bmjopen-2019-032851
  +Save
• Assessing Personalized Medicines in Australia
  Medical Decision Making 2013 DOI: 10.1177/0272989x12452341
  +Save